GOVERNMENT CONTRACT / PURCHASE ORDER
PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.
Awarded to LIFE TECHNOLOGIES CORPORATION
$17.5K
Data last updated Oct 22, 2026 · Source: USAspending
- Company legal name
- LIFE TECHNOLOGIES CORPORATION
- UEI / CAGE
- JXAKAG32BVN4 / Not reported
- Parent award
- Not reported
- Awarding agency
- Department of Health and Human Services
- Subagency
- Food and Drug Administration
- Industry
- Other
- NAICS
- 325413
- PSC
- 6505
- Performance period
- Not reported — Not reported
- Recipient address
- 3175 STALEY RD, GRAND ISLAND, ERIE, NY, 14072
- Place of performance
- SILVER SPRING, MONTGOMERY, MD, 20993
- Source last modified
- Nov 2, 2026
Description
PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.
Derived from official transactions
Contract lifecycle
- Award announced
PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.
- Value increased
PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.
Point-in-time model
Contract change outlook
Uncollapsed source history
Transactions and modifications
| Action date | Modification | Action type | Exact obligation | Current total | Potential total | Description | Source |
|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | 0 | Not reported | $17,500.00 | Not reported | Not reported | PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML. | USAspending ↗ |